Anika Therapeutics buy Barrington Research

Summary

This prediction is currently active. The BUY prediction by Barrington_Research for Anika Therapeutics is performing very badly with a performance of -54.87%. This prediction currently runs until 01.11.25. The prediction end date can be changed by Barrington_Research at any time. Barrington_Research has 50% into this prediction

Performance without dividends (%)

Name	1w	1m
Anika Therapeutics	-1.399%	-1.399%
iShares Core DAX®	3.109%	-0.124%
iShares Nasdaq 100	3.088%	4.723%
iShares Nikkei 225®	4.760%	5.051%
iShares S&P 500	1.840%	3.430%